Lacrofarm

Sodium hydrogen carbonate, potassium chloride, sodium chloride, macrogol 3350, the active ingredients in Lacrofarm, constitute an osmotic laxative presented as an oral formulation for systemic use. It is indicated for the relief of constipation and for bowel preparation before diagnostic procedures in adult patients.

GNH USA supplies Lacrofarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU‑based manufacturers to ensure quality and regulatory conformity. The company provides full regulatory documentation and supports import logistics for global partners.

Lacrofarm, an osmotic laxative, acts on the gastrointestinal tract to increase stool water content. - Constipation: facilitates softer stools and promotes regular bowel movements. - Bowel preparation: clears the intestinal lumen before colonoscopy or surgery. - Diagnostic procedures: provides effective cleansing for imaging studies requiring a clean colon.

Lacrofarm may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Mild abdominal cramps - Diarrhea - Increased thirst

Serious or Rare Side Effects: - Severe electrolyte imbalance - Dehydration - Allergic reaction (rash, itching) - Severe abdominal pain - Rectal bleeding - Anaphylaxis

When using Lacrofarm, consider the following precautions: - Assess renal function: adjust use in patients with impaired kidney function. - Monitor electrolytes: especially sodium and potassium levels during prolonged therapy. - Avoid in intestinal obstruction: risk of perforation. - Use with caution in elderly: higher susceptibility to dehydration. - Pregnancy and lactation: consult healthcare professional before use. - Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Lacrofarm can interact with other medicines; review the following categories:

Major Interactions (Avoid): - Concurrent use with other osmotic laxatives: may cause severe electrolyte disturbances. - Co‑administration with diuretics: increased risk of dehydration and electrolyte loss.

Moderate Interactions (Monitor Closely): - Antacids containing sodium or potassium: may alter electrolyte balance. - Mineral supplements: monitor serum levels. - Certain antibiotics (e.g., quinolones): reduced absorption due to delayed gastric emptying.